active: true
address:
    address1: 700 US HIGHWAY 202/206
    city: BRIDGEWATER
    postal_code: 08807
    state: NJ
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/aW5zbWVkLmNvbQ/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/aW5zbWVkLmNvbQ/images/2025-04-04_logo.svg
cik: '0001104506'
composite_figi: BBG000BWM5P3
currency_name: usd
description: Insmed Inc is a biopharmaceutical company transforming the lives of patients
    with serious and rare diseases. The company's first commercial product is ARIKAYCE
    (amikacin liposome inhalation suspension), approved in the United States for the
    treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination
    antibacterial drug regimen for adult patients with limited or no alternative treatment
    options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase
    1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil
    Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension
    linked to interstitial lung disease and pulmonary arterial hypertension.
homepage_url: https://www.insmed.com
list_date: '2000-06-01'
locale: us
market: stocks
market_cap: 25971619955.82
name: Insmed, Inc.
phone_number: 908-977-9900
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG001S9SKW7
share_class_shares_outstanding: 211374786
sic_code: '2834'
sic_description: PHARMACEUTICAL PREPARATIONS
ticker: INSM
ticker_root: INSM
total_employees: 1271
type: CS
weighted_shares_outstanding: 211374786
